Artesunate-mefloquine was as effective as the popular artemether-lumefantrine combo therapy.
Saudi Arabia's Ministry of Health (MOH) reported a new MERS-CoV infection, involving an 80-year-old woman from Jeddah who is a household contact of an earlier confirmed patient, and the World Health Organization (WHO) yesterday filled in more details about 13 recently reported cases from the country, 5 linked to a Riyadh hospital outbreak and at least 3 that appear to be linked to small clusters in Jeddah and Najran.
Both a promising vaccine and mass distribution of repellents failed to protect.
An outbreak of an especially large and severe enterovirus A71 (EV-A71) outbreak in kids younger than 10 in Spain's Catalonia region that began in the middle of April has so far sickened 87, with 22 still in the hospital, the European Centre for Disease Prevention and Control (ECDC) said today in a risk assessment.
The World Health Organization (WHO) today declared that Guinea has passed 42 days since the last patient was declared free of Ebola, officially ending Ebola virus transmission.
Global public health initiatives have cut malaria cases 37% and malaria deaths 60% since 2000 and led to other notable progress against the mosquito-borne disease, the World Health Organization (WHO) said today in a new report and press release to commemorate World Malaria Day.
Pet dogs and cats can be colonized with the MCR-1 antibiotic-resistance gene and pass it to people, Chinese researchers reported yesterday in a letter to Emerging Infectious Diseases. Their findings came from an investigation into MCR-1–harboring Escherichia coli isolates from three men hospitalized in a Guangzhou facility's urology ward toward the end of 2015.
The yellow fever vaccination campaign in Angola will be extended from Luanda province, the center of the ongoing outbreak, to more than 2 million people in Huambo and Huila provinces over the next few weeks, according to a press release yesterday from the World Health Organization (WHO).
Exceptional Ebola surveillance and swift responses to outbreaks will be the key to taking advantage of the availability of Ebola vaccines, say three experts who offered their thoughts on the future use of such vaccines in a new article from the World Health Organization (WHO).
Two studies show the effectiveness of artemisinin combo drugs in pregnant women.
